Published in Blood Weekly, January 12th, 2006
The data were presented as four separate posters at the American Society of Hematology's 47th Annual Meeting and Exposition in Atlanta, Georgia.
Gemin X also presented results from a phase I/II clinical trial of GX15-070 in patients with chronic lymphocytic leukemia (CLL) during the conference. The data indicated that GX15-070 was generally...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.